Implementation, target population, compliance and barriers to risk guided therapy

European Journal of Preventive Cardiology

Volumn 19, Issue , 2012, Pages 37-41

  Tokgozoglu, Lale ^a   Bruckert, Eric ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiovascular disease; guideline adherence; medication adherence; primary prevention; risk factors; secondary prevention

Indexed keywords

CARDIOVASCULAR DISEASE; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; HUMAN; PATIENT COMPLIANCE; PATIENT SELECTION; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; PATIENT COMPLIANCE; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84871689315     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487312448989     Document Type: Article

References (16)

1. Pyorala K, De Backer G, Graham I, et al. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–1331.
2. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14(Suppl. 2): S1–S113.
3. Yusuf S, Reddy S, Ounpuu S, et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855–2864.
4. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16: 121–137.
5. Banegas JR, Lopez-Garcia E, Dallongeville J, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J 2011; 32: 2143–2152.
6. Dallongeville J, Banegas JR, Tubach F, et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Cardiovasc Prev Rehabil. Epub ahead of print 18 April 2011. doi: 10.1177/1741826711407705.
7. Yusuf S, Islam S, Chow CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 2011; 378: 1231–1243.
8. Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract 2002; 19: 596–604.
9. Moschetti I, Brandt D, Perera R, et al. Adequacy of reporting monitoring regimens of risk factors for cardiovascular disease in clinical guidelines: systematic review. BMJ 2011; 342: d1289–d1289.
10. Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011; 217: 3–46.
11. Fletcher GF, Balady GJ and Vogel RA. Preventive cardiology: How can we do better? Proceedings of the 33rd Bethesda Conference. Bethesda, Maryland, USA. December 18, J Am Coll Cardiol 2002; 40: 580–651.
12. Piepoli M, Corrà U, Benzer W, et al. Secondary prevention through cardiac rehabilitation: from knowledge to implementation: a position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2010; 17: 1–17.
13. Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008; 371: 1999–2012.
14. Franchi D, Cini D, Iervasi G. A new web-based medical tool for assessment and prevention of comprehensive cardiovascular risk. Ther Clin Risk Manag 2011; 7: 59–68.
15. Colkesen EB, Ferket BS, Tijssen JG, et al. Effects on cardiovascular disease risk of a web-based health risk assessment with tailored health advice: a follow-up study. Vasc Health Risk Manag 2011; 7: 67–74.
16. Appel LJ, Clark JM, Yeh HC, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 2011; 365: 1959–1968.